Liquid Dosage

Therapeutical Proteins

Protein-based therapeutics are increasingly being developed as new chemical entities in the pharmaceutical and life science industries. Unlike small molecules, which are typically synthesized using chemical processes, most proteins need to be processed in living systems, mostly by recombinant DNA technology. The proteins can then be produced in their functional form (quaternary structure), rather than by microbial biosynthesis (bacteria/yeast), substantially reducing the downstream stages of the process.

The GEA Advantage

As the demand for large-volume products increases, so does the requirement for higher capacity reactors (up to 20,000 L) to realize economies of scale. GEA has responded to the changing needs of biopharmaceutical manufacturers and developed improved technology solutions to optimize both upstream and, with increasing titers, downstream processing, in terms of time and cost efficiency.

Based on its history of innovation and process development, GEA has a thorough working knowledge of therapeutic protein production and has used this competence to design better media and feeding strategies, optimize the fermentation stage and enhance physicochemical conditions during the manufacturing process.

A leading international supplier of integrated process systems, our extensive portfolio of products, technologies and services includes standard and customized fermenters, separators and entire production lines, as well as plant for the production, storage and distribution of clean utilities. Systems for the preparation of media, fluid management, cell cultivation and purification are also part of our global scope of supply.

As a competent manufacturer of complete plant for the life science industries, GEA is a full-service provider of solutions that meet your exact requirements and specifications. From planning, development and installation to qualification and maintenance, our experienced engineers will collaborate with your project team to supply innovative and efficient process solutions for your applications.

GEA Insights

Digitale Abwasseraufbereitung mit GEA Intellicant

Höhere Trockensubstanz, geringere Kosten, weniger Aufwand und konstantere Prozesse für Kläranlagen mit GEA Intellicant.

Computer generated AI in shape of brain.

Denk-Apparate: Klügere Maschinen, nachhaltigere Produktion

Mit progressiven Sensortechnologien, Cloud-Konnektivität und moderner Analytik verleiht GEA seinen leistungsstarken Maschinen nun eine eigene Intelligenz. Und es zeigt sich, dass KI die Leistung und Nachhaltigkeit von Produktionsprozessen...

GEA employees - separation

Das Beste herausholen

Die Geschichte der GEA-Zentrifugen beginnt 1893. Damals starteten Franz Ramesohl und Franz Schmidt mit der Herstellung ihrer patentierten Milchschleuder und ebneten damit den Weg für die moderne Milchverarbeitung. Mit ihrer Innovation...

Erhalten Sie Nachrichten von GEA

Informieren Sie sich über GEA Innovationen und Erfolgsgeschichten, indem Sie die News von GEA abonnieren.

Kontaktieren Sie uns

Wir helfen Ihnen gern weiter! Mit wenigen Details können wir Ihre Anfrage beantworten.

© GEA Group Aktiengesellschaft 2024

Cookie settings